I am pleased to share the final version of our Human Breast Cell Atlas with @MarioniLab now out @NatureGenet. There are important new additions, which I will leave to @Dr_SaraPensa and @AustinDReed to mention👇 . Couple of points i want to highlight 👇: https://t.co/tMCyMRJAdh

Thrilled our study on anti-progestin therapy for breast cancer prevention is out! A pleasure to be part of the team led by Bruno Simões, @RobClarkeLab + @DrSachaHowell, @MCRBreastCentre w @rmkhokha @WTKLAB. Team science moving us towards cancer prevention! https://t.co/gDsSLCunI9

PAPER OUT!! 🥳🥳🥳 Clinical potential of WGS data linked to mortality statistics in patients with breast cancer in England #shout out to #DaniellaBlack ⁦@GenomicsEngland⁩ ⁦ And all the patients that shared samples across @NHS 1/n

Could PARP inhibitors, targeted drugs already used to treat cancer, also help prevent it? We're part of a coalition of charities that believes the answer could be yes. And we're calling for urgent research to find out. https://t.co/NcyAYo2mtA

Excited to share our new preprint introducing CenSegNet, a deep learning framework for high-throughput, spatially resolved, single-cell centrosome profiling in heterogeneous tissues. Co-led by brilliant PhD students, Jiaoqi Cheng & Keqiang Fan. 1/3 https://t.co/OVzDIsGFba

Congratulations to the team on all their hard work on developing this first of its kind model! @Dan_Lester8 @aventura71 @psalmotoxin @WTKLAB @ShelleyBuffens1 @KYTsaiLab @LabElsaFlores @CD_AACR

Thrilled that our paper is finally in press @ScienceMagazine!! *Platelets sequester cell free DNA, including free fetal and tumour-derived DNA* Tweetorial from @l_cmurphy below. Check out the news feature https://t.co/r1bXqfpPSU and terrific editorial from Dennis Lo

We are recruiting….Any clinician interested in doing a PhD in London on lymphoma and mechanisms of transformation/ TME….please apply (and get in touch with us)

(1/12) Over a year ago, we launched a new project to explore whether the tissue microenvironment could predict cellular behaviour and whether reprogramming might unlock new therapeutic avenues. 🧬 Spatial transcriptomics provides deep insights into tissue organisation. We

Today saw our final year PhD students and MPhil students give talks on their research, whilst 2nd years presented posters of their progress so far 😀 A great day showing the diversity of research in the Department - congratulations to poster and talk prize winners!

We’re thrilled to share our latest publication in @Cancer_Cell, and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis

Not long left to apply! Join us at the Stem cells and Cancer conference in Malta. Deadline 31st July!

Could this be the future of cancer prevention? Walid Khaled @Cambridge_Uni, a new ERC Advanced Grant recipient, will work on a preventive vaccine for breast cancer. 👉 https://t.co/HbsTkUTx4W #ERCAdG #CancerResearch #FrontierResearch

How does tumour heterogeneity arise? How can we predict cancer cell plasticity? In 2 studies, we trace #glioblastoma heterogeneity to a spatial cancer cell trajectory w. atlassing https://t.co/OY9T4rHYrj & predict plasticity w. snRNA/ATAC+deep learning https://t.co/AwlOHu3cq6 🧵

We're recruiting a teaching associate to work across Biochemistry and Pharmacology! 🔬 The role focuses primarily on the delivery of teaching and examining but will also be involved in course development. Please apply here: https://t.co/sZQFvChZYY

A huge thank you to all patients, all the NHS hospital trusts, and trials teams that took part in the PARTNER trial @CUH_NHS; @CRUKCamBreast; @CRUKCamCentre; @Cambridge_Uni; @CambridgeBRC Thanks to @NatureComms and their editorial team!

Congrats to all the team. Important findings and hopefully will change practice.

Our Assistant/Associate Professor role closes in just a few days! See below to apply 🎓

Thanks to the team and collaborators @JCarrollLab, @LauraItzhaki @RahmanLab and funder @CRUKresearch @BreastCancerNow @UnivCamPharm @SCICambridge

We identify some chemical fragments that could disrupt the interaction BUT more work is needed to make them into potent drugs - I am open to discussions with industry and academic partners to make this happen.

If you are expecting UMAPs, you will be disappointed!! We found a TNBC specific protein-protein interaction between BCL11A and CHD8. We show that disrupting this interaction has the potential to specifically target TNBC without disrupting the other critical roles of BCL11A.